FDA — authorised 19 October 2009
- Application: NDA022465
- Marketing authorisation holder: NOVARTIS
- Local brand name: VOTRIENT
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 Votrient in United States
FDA authorised Votrient on 19 October 2009
Marketing authorisations
FDA
- Status: approved
Votrient in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Votrient approved in United States?
Yes. FDA authorised it on 19 October 2009; FDA has authorised it.
Who is the marketing authorisation holder for Votrient in United States?
NOVARTIS holds the US marketing authorisation.